Skip to main navigation Skip to search Skip to main content

Excellent outcomes in children and adolescents with CNS + Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

  • J. Kimble Frazer
  • , Kevin J. Li
  • , Paul J. Galardy
  • , Sherrie L. Perkins
  • , Anne Auperin
  • , James R. Anderson
  • , Ross Pinkerton
  • , Allen Buxton
  • , Thomas G. Gross
  • , Jean Michon
  • , Guy Leverger
  • , Howard J. Weinstein
  • , Lauren Harrison
  • , Bruce Shiramizu
  • , Mathew J. Barth
  • , Stanton C. Goldman
  • , Catherine Patte
  • , Mitchell S. Cairo
  • University of Oklahoma
  • Mayo Clinic Rochester, MN
  • University of Utah
  • Institut Gustave Roussy
  • Frontier Science and Technology Research Foundation
  • University of Queensland
  • CureSearch
  • National Institutes of Health
  • Institut Curie
  • Assistance publique – Hôpitaux de Paris
  • Massachusetts General Hospital
  • New York Medical College
  • University of Hawai'i at Mānoa
  • Medical City Children’s Hospital

Research output: Contribution to journalLetterpeer-review

29 Scopus citations
Original languageEnglish
Pages (from-to)374-377
Number of pages4
JournalBritish Journal of Haematology
Volume185
Issue number2
DOIs
StatePublished - Apr 2019

Keywords

  • B cell non-Hodgkin lymphoma
  • Burkitt lymphoma
  • central nervous system
  • paediatric
  • rituximab

Fingerprint

Dive into the research topics of 'Excellent outcomes in children and adolescents with CNS + Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1'. Together they form a unique fingerprint.

Cite this